A systematic analysis of methylene blue for drug-induced shock

Clinical Toxicology

Volumn 54, Issue 7, 2016, Pages 547-555

  Warrick, Brandon J ^a   Tataru, Anita Paula ^b   Smolinske, Susan ^a  

^a UNIVERSITY OF NEW MEXICO   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Beta blocker; calcium channel blocker; hypotension; intoxication; metformin

Indexed keywords

AMLODIPINE; ATENOLOL; CARBAMAZEPINE; DILTIAZEM; FLUOXETINE; IBUPROFEN; METFORMIN; METHYLENE BLUE; OXAZEPAM; QUETIAPINE; VALPROIC ACID; VERAPAMIL; CALCIUM CHANNEL BLOCKING AGENT; NITRIC OXIDE;

ARTICLE; BOLUS INJECTION; HUMAN; MAINTENANCE DRUG DOSE; META ANALYSIS; RESUSCITATION; SHOCK; SURVIVAL; CHEMICALLY INDUCED; EVIDENCE BASED MEDICINE; FACTUAL DATABASE; HEMODYNAMICS; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT OUTCOME;

CALCIUM CHANNEL BLOCKERS; DATABASES, FACTUAL; EVIDENCE-BASED MEDICINE; HEMODYNAMICS; HUMANS; METHYLENE BLUE; NITRIC OXIDE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SHOCK; TREATMENT OUTCOME;

EID: 84969626514     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.1080/15563650.2016.1180390     Document Type: Article

References (40)

1. J.L.Vincent, D.De Backer Circulatory shock. N Engl J Med. 2013;369:1726–1734.
2. J.B.Mowry, D.A.Spyker, D.E.Brooks,. 2014 Annual report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 32nd Annual Report. Clin Toxicol (Phila). 2015;53:962–1147.
3. M.Andresen, A.Dougnac, O.Díaz,. Use of methylene blue in patients with refractory septic shock: impact on hemodynamics and gas exchange. J Crit Care. 1998;13:164–168.
4. P.R.Evora, A.M.Oliveira-Neto, N.M.Duarte,. Methylene blue as treatment for contrast medium-induced anaphylaxis. J Postgrad Med. 2002;48:327.
5. Cochrane Haematological Malignancies Group. How to develop a search strategy for a Cochrane Review; [cited 2015 Aug 10] 2007. Available from: http://chmg-old.cochrane.org/sites/chmg-old.cochrane.org/files/uploads/How%20to%20develop%20a%20search%20strategy-support-manual.pdf.
6. OCEBM Levels of Evidence Working Group. The Oxford 2011 levels of evidence. Oxford center for evidence-based-medicine. [cited 2016 Jan 12]. Available from: http://www.cebm.net/index.aspx?o=5653.
7. D.H.Jang, L.S.Nelson, R.S.Hoffman Methylene blue in the treatment of refractory shock from an amlodipine overdose. Ann Emerg Med. 2011;58:565–567.
8. H.K.Kim, R.S.Hoffman, L.S.Nelson,. Methylene blue for refractory hypotension in cardiovascular drug overdose [abstract]. Clin Toxicol. 2012;50:365.
9. E.Kalimullah, S.Lee, D.Nelson Diltiazem levels after overdose in the setting of multiorgan failure and extracorporeal support Frazee [abstract]. Crit Care Med. 2013;41:A338.
10. N.Aggarwal, Y.Kupfer, C.Seneviratne,. Methylene blue reverses recalcitrant shock in β-blocker and calcium channel blocker overdose. BMJ Case Rep. 2013. doi:10.1136/bcr-2012-007402.
11. R.A.Jordanhazy, G.S.Swartzentruber, J.H.Yanta,. Case series of fatal calcium channel blocker overdoses treated with veno-arterial extracorporeal membrane oxygenation for refractory hypotension and shock [abstract]. Clin Toxicol. 2014;52:772.
12. J.R.Laes, D.M.Williams, K.G.Katzung,. Hemodialysis complications after intravenous fat emulsion administration [abstract]. Clin Toxicol. 2014;52:754.
13. S.Kazim, R.Chuang, V.Dias,. Treatment of massive verapamil overdose with peripheral veno-arterial extracorporeal membrane oxygenation [abstract]. Clin Toxicol. 2014;52:765.
14. R.L.Weinberg, N.C.Bouchard, D.C.Abrams,. Venoarterial extracorporeal membrane oxygenation for the management of massive amlodipine overdose. Perfusion. 2014;29:53–56.
15. L.Gérard, A.C.Galloy, A.Capron,. Mixed amlodipine/valsartan overdose treated by the molecular adsorbent recirculating system (MARS). Clin Toxicol. 2015;53:573–577.
16. Z.Livshits, L.S.Nelson, S.H.Hernandez,. Severe metformin toxicity: role of methylene blue and CVVHD as therapeutic adjuncts [abstract]. Clin Toxicol. 2010;48:611–612.
17. B.Plumb, A.Parker, P.Wong Feeling blue with metformin-associated lactic acidosis. BMJ Case Rep. 2013. doi:10.1136/bcr-2013-008855.
18. J.Höjer, J.Westerbergh, M.Edfeldt-Ugarph,. Metylenblåu hävde metformin associerad laktacidos. [Methylene blue stopped metformin-associated lactic acidosis.]. Läkartidningen. 2013;110:1865–1866.
19. J.Westerbergh, J.Höjer Metformin-induced refractory vasodilatory shock successfully treated with methylene blue [abstract]. Clin Toxicol. 2013;51:364.
20. D.Heredia, E.Mancl, B.Sayegh,. Successful use of methylene blue for hemodynamically unstable metformin toxicity [abstract]. Chest. 2014;146:253A.
21. R.E.Graham, M.Cartner, J.Winearls A severe case of vasoplegic shock following metformin overdose successfully treated with methylene blue as a last line therapy. BMJ Case Rep. 2015. doi:s10.1136/bcr-2015-210229.
22. J.Fisher, G.Taori, G.Braitberg,. Methylene blue used in the treatment of refractory shock resulting from drug poisoning. Clin Toxicol (Phila). 2014;52:63–65.
23. S.C.Curry, M.Levine, R.French,. Cardiovascular collapse and shock following ibuprofen ingestion [abstract]. Clin Toxicol. 2011;49:616.
24. D.French, C.Smollin, W.Ruan,. Partition constant and volume of distribution as predictors of clinical efficacy of lipid rescue for toxicological emergencies. Clin Toxicol. 2011;49:801–809.
25. R.C.Baselt Disposition of toxic drugs and chemicals in man. Seal Beach: Biomedical Publications; 2014:1312–1313.
26. National Center for Biotechnology Information. Pubchem compound database; CID =6099; 2005. [cited 2016 Apr 1]. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/6099.
27. Y.Ding, N.D.Vaziri Calcium channel blockade enhances nitric oxide synthase expression by cultured endothelial cells. Hypertension. 1998;32:718–723.
28. X.Zhang, T.H.Hintze Amlodipine releases nitric oxide from canine coronary microvessels: an unexpected mechanism of action of a calcium channel-blocking agent. Circulation. 1998;97:576–580.
29. B.J.Davis, Z.Xie, B.Viollet,. Activation of the AMP-activated kinase by antidiabetes drug metformin stimulates nitric oxide synthesis in vivo by promoting the association of heat shock protein 90 and endothelial nitric oxide synthase. Diabetes. 2006;55:496–505.
30. N.P.Juffermans, M.G.Vervloet, C.R.Daemen-Gubbels,. A dose-finding study of methylene blue to inhibit nitric oxide actions in the hemodynamics of human septic shock. Nitric Oxide. 2010;22:275–280.
31. T.Sonobe, P.Haouzi H2S induced coma and cardiogenic shock in the rat: effects of phenothiazinium chromophores. Clin Toxicol (Phila). 2015;53:525–539.
32. D.H.Jang, S.Donovan, L.S.Nelson,. Efficacy of methylene blue in an experimental model of calcium channel blocker-induced shock. Ann Emerg Med. 2014;65:410–415.
33. N.Blass, D.Fung. Dyed but not dead-methylene blue overdose. Anesthesiology. 1976;45:458–459.
34. H.Gourlain, F.Buneaux, S.W.Borron,. Interference of methylene blue with co-oximetry of hemoglobin derivatives. Clin Chem. 1997;43:1078–1080.
35. K.K.Bach, F.W.Lindsay, L.S.Berg,. Prolonged postoperative disorientation after methylene blue infusion during parathyroidectomy. Anesth Analg. 2004;99:1573–1574.
36. S.S.Kartha, C.E.Chacko, J.M.Bumpous,. Toxic metabolic encephalopathy after parathyroidectomy with methylene blue localization. Otolaryngol Head Neck Surg. 2006;135:765–768.
37. G.Sweet, S.B.Standiford Methylene-blue-associated encephalopathy. J Am Coll Surg. 2007;204:454–458.
38. FDA Drug Safety Communication. Serious CNS reactions possible when methylene blue is given to patients taking certain psychiatric medications; [cited 2015 Nov 6]. Available from: http://www.fda.gov/Drugs/DrugSafety/ucm263190.htm.
39. A.A.Birch, W.H.Boyce Hypertension and decreased renal blood flow following methylene blue injection. Anesth Analg. 1976;55:674–676.
40. U.Khanduri, A.Sharma, P.Kumar Unique red cell abnormality in a case of fatal methylene blue induced haemolysis. Hematology. 2004;9:239–241.